Skip to content

Remote Monitoring and Management of Rehabilitation Status in Sepsis Patients After Discharge Based on Smart Watch

Remote Monitoring and Management of Rehabilitation Status in Sepsis Patients After Discharge Based on Smart Watch

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123357
Enrollment
Unknown
Registered
2026-04-24
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Intervention Group:Intervention Group: Wearing smart wearable devices (collecting vital signs such as heart rate, blood oxygen, body temperature, blood pressure) + AI-based remote monitoring and rehab
Control Group:Control Group: Routine health education + telephone follow-up (without smart device intervention).

Sponsors

Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the Sepsis-3.0 diagnostic criteria for sepsis with low mortality risk within 28 days after discharge; 2. Aged >=18 years old, regardless of gender; 3. Having complete clinical data (including diagnosis, laboratory tests, treatment history, etc.); 4. Being proficient in using smart wearable devices/mobile APPs, or having family members to assist in operation; 5. Signing the informed consent form and voluntarily participating in the study.

Exclusion criteria

Exclusion criteria: 1. Not meeting the sepsis diagnostic criteria or having controversial diagnosis; 2. Aged <18 years old; 3. Complicated with cognitive impairment, mental illness, or being unable to cooperate with the study process/with extremely poor compliance; 4. Unable to maintain long-term follow-up contact with high risk of loss; 5. Expected survival time <28 days, or complicated with severe malignant tumors or end-stage organ failure; 6. Refusing to participate in the study or wear smart wearable devices; 7. Having contraindications for smart device use (such as severe skin allergy)

Design outcomes

Primary

MeasureTime frame
12-month Survival Rate;

Secondary

MeasureTime frame
Readmission Rate;Outpatient Visit Rate;ED Visit Rate;Quality of Life (EQ-5D-5L);

Countries

China

Contacts

Public ContactJianguo Zhang

Affiliated Hospital of Jiangsu University

1000011431@ujs.edu.cn+86 137 7553 6650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026